Prognostic Impact of Renin-Angiotensin Inhibitors in Patients with Bladder Cancer Undergoing Radical Cystectomy. (Q53011547)

10 May 2018

title

Prognostic Impact of Renin-Angiotensin Inhibitors in Patients with Bladder Cancer Undergoing Radical Cystectomy. (English)

1 reference

10 May 2018

1 reference

Takashi Yoshida

1

1 reference

10 May 2018

Hidefumi Kinoshita

2

1 reference

10 May 2018

Katsuya Fukui

3

1 reference

10 May 2018

Tomoaki Matsuzaki

4

1 reference

10 May 2018

Kenji Yoshida

5

1 reference

10 May 2018

Takao Mishima

6

1 reference

10 May 2018

Masaaki Yanishi

7

1 reference

10 May 2018

Yoshihiro Komai

8

1 reference

10 May 2018

Motohiko Sugi

9

1 reference

10 May 2018

Takaaki Inoue

10

1 reference

10 May 2018

Takashi Murota

11

1 reference

10 May 2018

Tadashi Matsuda

12

1 reference

10 May 2018

publication date

11 October 2016

1 reference

10 May 2018

Annals of Surgical Oncology

published in

1 reference

10 May 2018

volume

24

1 reference

10 May 2018

issue

3

1 reference

10 May 2018

page(s)

823-831

1 reference

10 May 2018

https://scigraph.springernature.com/pub.10.1245/s10434-016-5534-3

exact match

0 references

cites work

Update on chemotherapy for advanced bladder cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5534-3

Radical cystectomy for invasive bladder cancer: results of multi-institutional pooled analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5534-3

EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5534-3

Acquired platinum resistance enhances tumour angiogenesis through angiotensin II type 1 receptor in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5534-3

Targeting the VEGF pathway in metastatic bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5534-3

A phase II safety and efficacy study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor pazopanib in patients with metastatic urothelial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5534-3

Cis-dichlorodiammineplatinum upregulates angiotensin II type 1 receptors through reactive oxygen species generation and enhances VEGF production in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5534-3

Prognostic value of renin-angiotensin system blockade in non-muscle-invasive bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5534-3

Renin-Angiotensin Inhibitors Decrease Recurrence after Transurethral Resection of Bladder Tumor in Patients with Nonmuscle Invasive Bladder Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5534-3

Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5534-3

Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5534-3

Transforming growth factor-beta: a clinical target for the treatment of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5534-3

The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5534-3

Angiotensin II/angiotensin II type I receptor (AT1R) signaling promotes MCF-7 breast cancer cells survival via PI3-kinase/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5534-3

Angiotensin II Type 1 Receptor Antagonist as an Angiogenic Inhibitor in Urogenital Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5534-3

Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC grafts in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5534-3

Expression and role of the angiotensin II AT2 receptor in human prostate tissue: in search of a new therapeutic option for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5534-3

Angiotensin II type 1 receptor antagonist candesartan as an angiogenic inhibitor in a xenograft model of bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5534-3

Renin-angiotensin system blockade: Its contribution and controversy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5534-3

Effect of angiotensin II type 1 receptor antagonist on tumor growth and angiogenesis in a xenograft model of human bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5534-3

Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5534-3

Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5534-3

A cohort study of antihypertensive medication use and breast cancer among Danish women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5534-3

Antihypertensive drug use and the risk of prostate cancer (Canada)

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5534-3

10.1245/S10434-016-5534-3

21 January 2018

Identifiers

DOI

1 reference

10 May 2018

Dimensions Publication ID

0 references

1 reference

10 May 2018